Since previous studies have indicated tumour recurrence to be related to radio-resistance (Chen et al., 2014; Yang et al., 2020), these findings collectively indicate that ANG expression may be an important biomarker of radio-resistance in patients with NPC. The gene discussed is ANG; the disease is nasopharyngeal carcinoma.